Impact of Uruguay's introduction of the Haemophilus influenzae type b (Hib) vaccine.
D000293:Adolescent; D000367:Age Factors; D000569:Americas; D001695:Biology; D002490:Central Nervous System; D002648:Child; D003695:Delivery of Health Care; D003710:Demography; D003906:Developing Countries; D004194:Disease; D006262:Health; D006296:Health Services; D007114:Immunization; D015994:Incidence; D007239:Infections; D007843:Latin America; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D011320:Primary Health Care; D012106:Research; D012107:Research Design; D013020:South America; D014583:Uruguay; D014611:Vaccination; D014612:Vaccines
D014612:Vaccines
Age Factors; Americas; Bacterial And Fungal Diseases; Biology; Central Nervous System; Central Nervous System Effects; Child; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Health; Health Services; Immunization; Incidence; Infections; Latin America; Measurement; Physiology; Population; Population Characteristics; Primary Health Care; Research Methodology; South America; Uruguay; Vaccination; Vaccines--administraction and dosage; Youth